Multiple approaches to associations of physical activity and adherence to the Mediterranean diet with all-cause mortality in older adults: the PREvención con DIeta MEDiterránea study.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 18 10 2017
accepted: 13 04 2018
pubmed: 27 4 2018
medline: 23 1 2020
entrez: 27 4 2018
Statut: ppublish

Résumé

Although evidence indicates that both physical activity and adherence to the Mediterranean diet (MedDiet) reduce the risk of all-cause mortality, a little is known about optimal intensities of physical activity and their combined effect with MedDiet in older adults. We assessed the separate and combined associations of leisure-time physical activity (LTPA) and MedDiet adherence with all-cause mortality. We prospectively studied 7356 older adults (67 ± 6.2 years) at high vascular risk from the PREvención con DIeta MEDiterránea study. At baseline and yearly thereafter, adherence to the MedDiet and LTPA were measured using validated questionnaires. After 6.8 years of follow-up, we documented 498 deaths. Adherence to the MedDiet and total, light, and moderate-to-vigorous LTPA were inversely associated with all-cause mortality (p < 0.01 for all) in multiple adjusted Cox regression models. The adjusted hazard of all-cause mortality was 73% lower (hazard ratio 0.27, 95% confidence interval 0.19-0.38, p < 0.001) for the combined category of highest adherence to the MedDiet (3rd tertile) and highest total LTPA (3rd tertile) compared to lowest adherence to the MedDiet (1st tertile) and lowest total LTPA (1st tertile). Reductions in mortality risk did not meaningfully differ between total, light intensity, and moderate-to-vigorous LTPA. We found that higher levels of LTPA, regardless of intensity (total, light and moderate-to-vigorous), and greater adherence to the MedDiet were associated separately and jointly with lower all-cause mortality. The finding that light LTPA was inversely associated with mortality is relevant because this level of intensity is a feasible option for older adults.

Identifiants

pubmed: 29696401
doi: 10.1007/s00394-018-1689-y
pii: 10.1007/s00394-018-1689-y
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1569-1578

Subventions

Organisme : ISCIII and Health Department of the Catalan Government
ID : CP 06/00100
Organisme : FEDER
ID : CB06/03
Organisme : CIBEROBN
ID : G03/140
Organisme : CIBEROBN
ID : RD 06/0045
Organisme : Centro Nacional de Investigaciones Cardiovasculares
ID : CNIC 06/2007
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI04-2239
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI05/2584
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : CP06/00100
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI07/0240
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI07/1138
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI07/0954
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI 07/0473
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI10/01407
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI10/02658
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI11/01647
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI11/02505
Organisme : Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional
ID : PI13/00462
Organisme : Ministerio de Ciencia, Tecnología e Innovación Productiva
ID : AGL-2009-13906-C02
Organisme : Ministerio de Ciencia, Tecnología e Innovación Productiva
ID : AGL2010-22319-C03
Organisme : Consejería de Salud de la Junta de Andalucía
ID : PI0105/2007
Organisme : Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana
ID : ACOMP06109
Organisme : Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana
ID : GVA-COMP2010-181
Organisme : Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana
ID : GVACOMP2011-151
Organisme : Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana
ID : CS2010-AP-111
Organisme : Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana
ID : CS2011-AP-042
Organisme : Navarra Regional Government
ID : 27/2011

Références

Br J Sports Med. 2015 Oct;49(19):1262-7
pubmed: 26238869
Ann Intern Med. 2006 Jul 4;145(1):1-11
pubmed: 16818923
BMC Public Health. 2015 Feb 12;15:133
pubmed: 25879680
Maturitas. 2013 Mar;74(3):246-51
pubmed: 23280132
J Am Geriatr Soc. 2014 Nov;62(11):2079-87
pubmed: 25367147
J Nutr Health Aging. 2017;21(5):505-513
pubmed: 28448080
Lancet. 2016 Sep 24;388(10051):1302-10
pubmed: 27475271
J Nutr. 2011 Jun;141(6):1140-5
pubmed: 21508208
Int J Behav Nutr Phys Act. 2014 Oct 24;11:132
pubmed: 25344355
JAMA Intern Med. 2016 Jun 1;176(6):816-25
pubmed: 27183032
Am J Clin Nutr. 2015 Mar;101(3):613-21
pubmed: 25733647
Lancet. 2017 Apr 1;389(10076):1323-1335
pubmed: 28236464
J Hum Nutr Diet. 2017 Apr;30(2):216-226
pubmed: 27620213
J Chronic Dis. 1978;31(12):741-55
pubmed: 748370
JAMA. 2004 Sep 22;292(12):1433-9
pubmed: 15383513
Br J Nutr. 2010 Jun;103(12):1808-16
pubmed: 20102675
Med Sci Sports Exerc. 2015 Sep;47(9):1833-40
pubmed: 25628179
Nutr Hosp. 2016 Dec 07;33(Suppl 8):1-48
pubmed: 28196425
Eur J Clin Nutr. 2018 Jan;72(1):30-43
pubmed: 28488692
Am J Clin Nutr. 2016 Nov;104(5):1424-1432
pubmed: 27707702
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
PLoS Med. 2012;9(11):e1001335
pubmed: 23139642
Public Health Nutr. 2010 Sep;13(9):1364-72
pubmed: 20105389
Int J Epidemiol. 2012 Apr;41(2):377-85
pubmed: 21172932
Br J Nutr. 2015 Jan 14;113(1):16-24
pubmed: 25430485
Am J Prev Med. 2017 Jan;52(1):e25-e31
pubmed: 27816381
Med Sci Sports Exerc. 2000 Aug;32(8):1431-7
pubmed: 10949009
PLoS One. 2016 Aug 10;11(8):e0159252
pubmed: 27509006
Am J Epidemiol. 1994 Jun 15;139(12):1197-209
pubmed: 8209878
Am J Clin Nutr. 2017 Jun;105(6):1399-1407
pubmed: 28424183
Eur J Epidemiol. 2013 May;28(5):361-72
pubmed: 23532745
J Nutr Biochem. 2007 Mar;18(3):149-60
pubmed: 16963247
Med Sci Sports Exerc. 2016 Jul;48(7):1303-11
pubmed: 26848889

Auteurs

Gabriela Cárdenas-Fuentes (G)

Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
PhD Programme in Biomedicine, Department of Experimental and Health Sciences, Universidad Pompeu Fabra, Barcelona, Spain.

Isaac Subirana (I)

Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
CIBER Epidemiologia y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

Miguel A Martinez-Gonzalez (MA)

Department of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Department of Nutrition, Harvard TH Chan School of Public Health, Boston, USA.

Jordi Salas-Salvadó (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Human Nutrition Unit, Department of Biochemistry and Biotechnology, Pere Virgili Institute for Health Research, University Hospital of Sant Joan de Reus, Rovira i Virgili University, Reus, Spain.

Dolores Corella (D)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, Valencia, Spain.

Ramon Estruch (R)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Department of Internal Medicine, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

Montserrat Fíto (M)

Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.

Carlos Muñoz-Bravo (C)

Department of Public Health and Psychiatry, University of Málaga, Málaga, Spain.

Miguel Fiol (M)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Institute of Health Sciences, University of Balearic Islands and Son Espases Hospital, Palma de Mallorca, Spain.

José Lapetra (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Department of Family Medicine, Distrito Sanitario Atención Primaria Sevilla, Research Unit, Seville, Spain.

Fernando Aros (F)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Department of Cardiology, University Hospital Araba, Vitoria, Spain.

Luis Serra-Majem (L)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Department of Clinical Sciences, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.

Josep A Tur (JA)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Research Group on Community Nutrition and Oxidative Stress, Universitat de les Illes Balears, Palma de Mallorca, Spain.

Xavier Pinto (X)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Lipids and Vascular Risk Units, Internal Medicine, University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Emilio Ros (E)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Lipid Clinic, Endocrinology and Nutrition Service, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.

Oscar Coltell (O)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Department of Computer Languages and Systems, Universitat Jaume I, Castellon, Spain.

Andres Díaz-López (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
Human Nutrition Unit, Department of Biochemistry and Biotechnology, Pere Virgili Institute for Health Research, University Hospital of Sant Joan de Reus, Rovira i Virgili University, Reus, Spain.

Miguel Ruiz-Canela (M)

Department of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.

Helmut Schröder (H)

Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. hschroeder@imim.es.
CIBER Epidemiologia y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. hschroeder@imim.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH